|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tamura G: Genetic and epigenetic
alterations of tumor suppressor and tumor-related genes in gastric
cancer. Histol Histopathol. 17:323–329. 2002.PubMed/NCBI
|
|
5
|
Zhong JL and Huang CZ: Ubiquitin
proteasome system research in gastrointestinal cancer. World J
Gastrointest Oncol. 8:198–206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hao Z, Zhang H and Cowell J:
Ubiquitin-conjugating enzyme UBE2C: Molecular biology, role in
tumorigenesis, and potential as a biomarker. Tumour Biol.
33:723–730. 2012. View Article : Google Scholar
|
|
7
|
Xie C, Powell C, Yao M, Wu J and Dong Q:
Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker. Int
J Biochem Cell Biol. 47:113–117. 2014. View Article : Google Scholar
|
|
8
|
Wagner KW, Sapinoso LM, El-Rifai W,
Frierson HF, Butz N, Mestan J, Hofmann F, Deveraux QL and Hampton
GM: Overexpression, genomic amplification and therapeutic potential
of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of
diverse anatomic origin. Oncogene. 23:6621–6629. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wing SS and Jain P: Molecular cloning,
expression and characterization of a ubiquitin conjugation enzyme
(E217kB) highly expressed in rat testis. Biochem J.
305:125–132. 1995. View Article : Google Scholar
|
|
10
|
Jiang L, Huang CG, Lu YC, Luo C, Hu GH,
Liu HM, Chen JX and Han HX: Expression of ubiquitin-conjugating
enzyme E2C/UbcH10 in astrocytic tumors. Brain Res. 1201:161–166.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chou CP, Huang NC, Jhuang SJ, Pan HB, Peng
NJ, Cheng JT, Chen CF, Chen JJ and Chang TH: Ubiquitin-conjugating
enzyme UBE2C is highly expressed in breast microcalcification
lesions. PLoS One. 9:e939342014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perrotta I, Bruno L, Maltese L, Russo E,
Donato A and Donato G: Immunohistochemical analysis of the
ubiquitin-conjugating enzyme UbcH10 in lung cancer: A useful tool
for diagnosis and therapy. J Histochem Cytochem. 60:359–365. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pallante P, Malapelle U, Berlingieri MT,
Bellevicine C, Sepe R, Federico A, Rocco D, Galgani M, Chiariotti
L, Sanchez-Cespedes M, et al: UbcH10 overexpression in human lung
carcinomas and its correlation with EGFR and p53 mutational status.
Eur J Cancer. 49:1117–1126. 2013. View Article : Google Scholar
|
|
14
|
Pallante P, Berlingieri MT, Troncone G,
Kruhoffer M, Orntoft TF, Viglietto G, Caleo A, Migliaccio I,
Decaussin-Petrucci M, Santoro M, et al: UbcH10 overexpression may
represent a marker of anaplastic thyroid carcinomas. Br J Cancer.
93:464–471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin J, Raoof DA, Wang Z, Lin MY, Thomas
DG, Greenson JK, Giordano TJ, Orringer MB, Chang AC, Beer DG, et
al: Expression and effect of inhibition of the
ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.
Neoplasia. 8:1062–1071. 2006. View Article : Google Scholar
|
|
16
|
Ieta K, Ojima E, Tanaka F, Nakamura Y,
Haraguchi N, Mimori K, Inoue H, Kuwano H and Mori M: Identification
of overexpressed genes in hepatocellular carcinoma, with special
reference to ubiquitin-conjugating enzyme E2C gene expression. Int
J Cancer. 121:33–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bavi P, Uddin S, Ahmed M, Jehan Z, Bu R,
Abubaker J, Sultana M, Al-Sanea N, Abduljabbar A, Ashari LH, et al:
Bortezomib stabilizes mitotic cyclins and prevents cell cycle
progression via inhibition of UBE2C in colorectal carcinoma. Am J
Pathol. 178:2109–2120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li SZ, Song Y, Zhang HH, Jin BX, Liu Y,
Liu WB, Zhang XD and Du RL: UbcH10 overexpression increases
carcinogenesis and blocks ALLN susceptibility in colorectal cancer.
Sci Rep. 4:69102014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen S, Chen Y, Hu C, Jing H, Cao Y and
Liu X: Association of clinicopathological features with UbcH10
expression in colorectal cancer. J Cancer Res Clin Oncol.
136:419–426. 2010. View Article : Google Scholar
|
|
20
|
van Ree JH, Jeganathan KB, Malureanu L and
van Deursen JM: Overexpression of the E2 ubiquitin-conjugating
enzyme UbcH10 causes chromosome missegregation and tumor formation.
J Cell Biol. 188:83–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukasawa K: Oncogenes and tumour
suppressors take on centrosomes. Nat Rev Cancer. 7:911–924. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu N, Wang Z, Song X, Wei L, Kim BS,
Freedman ND, Baek J, Burdette L, Chang J, Chung C, et al:
Genome-wide association study of gastric adenocarcinoma in Asia: A
comparison of associations between cardia and non-cardia tumours.
Gut. 65:1611–1618. 2016. View Article : Google Scholar
|
|
23
|
Oh S and Oh S: Epidemiological and
genome-wide association study of gastritis or gastric ulcer in
korean populations. Genomics Inform. 12:127–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saeki N, Ono H, Sakamoto H and Yoshida T:
Genetic factors related to gastric cancer susceptibility identified
using a genome-wide association study. Cancer Sci. 104:1–8. 2013.
View Article : Google Scholar
|
|
25
|
Liu X, Li Z, Song Y, Wang R, Han L, Wang
Q, Jiang K, Kang C and Zhang Q: AURKA induces EMT by regulating
histone modification through Wnt/β-catenin and PI3K/Akt signaling
pathway in gastric cancer. Oncotarget. 7:33152–33164.
2016.PubMed/NCBI
|
|
26
|
Mahankali M, Henkels KM, Gomez-Cambronero
J and Speranza F: A non-mitotic role for Aurora kinase A as a
direct activator of cell migration upon interaction with PLD, FAK
and Src. J Cell Sci. 128:516–526. 2015. View Article : Google Scholar :
|
|
27
|
Do TV, Xiao F, Bickel LE, Klein-Szanto AJ,
Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, et al:
Aurora kinase A mediates epithelial ovarian cancer cell migration
and adhesion. Oncogene. 33:539–549. 2014. View Article : Google Scholar
|
|
28
|
Tong T, Zhong Y, Kong J, Dong L, Song Y,
Fu M, Liu Z, Wang M, Guo L, Lu S, et al: Overexpression of Aurora-A
contributes to malignant development of human esophageal squamous
cell carcinoma. Clin Cancer Res. 21:7304–7310. 2004. View Article : Google Scholar
|
|
29
|
Zhang Y, Han T, Wei G and Wang Y:
Inhibition of microRNA-17/20a suppresses cell proliferation in
gastric cancer by modulating UBE2C expression. Oncol Rep.
33:2529–2536. 2015.PubMed/NCBI
|
|
30
|
Shuliang S, Lei C, Guangwu J and Changjie
L: Involvement of ubiquitin-conjugating enzyme E2C in proliferation
and invasion of prostate carcinoma cells. Oncol Res. 21:121–127.
2013. View Article : Google Scholar
|
|
31
|
Rape M, Reddy SK and Kirschner MW: The
processivity of multiubiquitination by the APC determines the order
of substrate degradation. Cell. 124:89–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alfieri C, Chang L, Zhang Z, Yang J,
Maslen S, Skehel M and Barford D: Molecular basis of APC/C
regulation by the spindle assembly checkpoint. Nature. 536:431–436.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garvanska DH, Larsen MS and Nilsson J:
Synergistic inhibition of the APC/C by the removal of APC15 in
HCT116 cells lacking UBE2C. Biol Open. 5:1441–1448. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vasiljevic A, Champier J,
Figarella-Branger D, Wierinckx A, Jouvet A and Fevre-Montange M:
Molecular characterization of central neurocytomas: Potential
markers for tumor typing and progression. Neuropathology.
33:149–161. 2013. View Article : Google Scholar
|
|
35
|
Gheldof A and Berx G: Cadherins and
epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci.
116:317–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dar AA, Belkhiri A and El-Rifai W: The
aurora kinase A regulates GSK-3β in gastric cancer cells. Oncogene.
28:866–875. 2009. View Article : Google Scholar
|
|
37
|
Radice GL: N-cadherin-mediated adhesion
and signaling from development to disease: Lessons from mice. Prog
Mol Biol Transl Sci. 116:263–289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee JY and Kong G: Roles and epigenetic
regulation of epithelial-mesenchymal transition and its
transcription factors in cancer initiation and progression.
Cellular and molecular life sciences. Cell Mol Life Sci.
73:4643–4660. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Phillips S and Kuperwasser C: SLUG:
Critical regulator of epithelial cell identity in breast
development and cancer. Cell Adhes Migr. 8:578–587. 2014.
View Article : Google Scholar
|
|
40
|
Zhang P, Hu P, Shen H, Yu J, Liu Q and Du
J: Prognostic role of Twist or Snail in various carcinomas: A
systematic review and meta-analysis. Eur J Clin Invest.
44:1072–1094. 2014. View Article : Google Scholar : PubMed/NCBI
|
